All data are based on the daily closing price as of September 5, 2025
s
Seegene
096530.KQ
18.61 USD
0.16
+0.87%
Overview
Last close
18.61 usd
Market cap
858.07M usd
52 week high
25.81 usd
52 week low
14.21 usd
Target price
31.02 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.6243
Price/Book Value
1.2037
Enterprise Value
567.43M usd
EV/Revenue
1.7317
EV/EBITDA
12.1639
Key financials
Revenue TTM
327.68M usd
Gross Profit TTM
196.31M usd
EBITDA TTM
63.70M usd
Earnings per Share
N/A usd
Dividend
0.58 usd
Total assets
895.44M usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.